CPHI Milan Leadership Summit Sets Its Sights On Pharmaceutical Supply Chain Challenges

The CPHI Milan Leadership Summit is set to return with a sharp focus on supply chain resilience, one of the pharmaceutical industry’s most pressing concerns heading into late 2026.

Supply chain disruption has remained a defining challenge for the global pharmaceutical sector, with manufacturers and distributors continuing to navigate complex logistical pressures across international markets.

The summit brings together senior industry figures to address these challenges directly, offering a platform for strategic dialogue at one of the world’s most prominent pharmaceutical gatherings.

Meanwhile, behind the scenes of LogiPharma USA 2026, key industry voices have been sharing their perspectives on the evolving landscape of pharmaceutical logistics and distribution.

Program director Charleen Ring has been central to shaping the LogiPharma USA 2026 agenda, helping guide conversations around the most critical supply chain priorities facing the sector today.

Joining Ring in a special Pharma Pulse feature is McKesson’s Chris Van Norman, whose insights reflect the operational realities facing one of the industry’s leading distribution organisations.

McKesson remains a significant force in pharmaceutical distribution, and Van Norman’s perspective adds considerable weight to discussions around supply chain strategy and infrastructure.

The Pharma Pulse feature offers an inside look at how industry leaders are approaching logistics challenges, drawing on first-hand experience from both event organizers and major industry players.

As the CPHI Milan Leadership Summit approaches, supply chain topics are expected to dominate the agenda, reflecting broader anxieties about drug availability, manufacturing capacity, and cross-border distribution.

The convergence of major pharmaceutical events in 2026 underscores the sector’s urgency in building more robust, transparent, and agile supply chains capable of withstanding future shocks.

Industry gatherings like CPHI Milan and LogiPharma USA continue to serve as vital spaces where pharmaceutical leaders align on strategy, share operational intelligence, and chart a course through an increasingly complex global environment.